Syngene International Limited
SYNGENE · General/Diversified · NSE
₹455
Current Market Price
Fair Value (DCF)
₹250
Discount to FV
-45.1%
Updated 1h ago
YieldIQ Score
46/100
Piotroski F-Score
7/9
Economic Moat
Narrow
Confidence
65%
ROE
10.5%
Debt/Equity
0.12
WACC
10.5%
Market Cap
₹18,294 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
21.5%
Return on capital employed
EV / EBITDA
17.9×
Enterprise multiple
Debt / EBITDA
0.6×
Leverage vs earnings
Interest Coverage
14.4×
EBIT covers interest
Current Ratio
1.64×
Short-term liquidity
Asset Turnover
0.55×
Revenue per ₹ of assets
Revenue CAGR (3Y)
2.5%
3-year revenue growth
Revenue CAGR (5Y)
7.6%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹455.35
Bear case
Margin of Safety —
Implied upside -207.2%
Base case
Margin of Safety -465.5%
Implied upside -82.3%
Bull case
Margin of Safety -68.0%
Implied upside -40.5%
Ratio Trends
SYNGENE · last 7 annual periods
ROE
10.5%
ROCE
21.5%
Operating Margin
—
Debt / Equity
0.12×
PE
133.7×
EV / EBITDA
24.0×
Historical Financials
SYNGENE · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹2507 Cr | ₹3080 Cr | ₹3370 Cr | ₹3642 Cr | ₹3739 Cr | +10.5% |
| EBITDA | ₹812 Cr | ₹995 Cr | ₹1092 Cr | ₹1146 Cr | ₹913 Cr | +3.0% |
| EBIT | ₹509 Cr | ₹639 Cr | ₹668 Cr | — | — | +7.1% |
| PAT | ₹396 Cr | ₹464 Cr | ₹510 Cr | ₹496 Cr | ₹317 Cr | -5.4% |
| EPS (diluted) | ₹9.82 | ₹11.51 | ₹12.69 | — | — | +6.6% |
| CFO | ₹581 Cr | ₹824 Cr | ₹1042 Cr | ₹1168 Cr | ₹915 Cr | +12.0% |
| CapEx | ₹-476 Cr | ₹-518 Cr | ₹-511 Cr | ₹-770 Cr | ₹-368 Cr | — |
| FCF | ₹105 Cr | ₹305 Cr | ₹531 Cr | ₹398 Cr | ₹547 Cr | +51.0% |
| Total Assets | ₹5564 Cr | ₹5831 Cr | ₹6152 Cr | ₹6796 Cr | ₹7055 Cr | +6.1% |
| Total Debt | ₹1022 Cr | ₹815 Cr | ₹555 Cr | ₹578 Cr | ₹458 Cr | -18.2% |
| Shareholders' Equity | ₹3298 Cr | ₹3618 Cr | ₹4258 Cr | ₹4727 Cr | ₹4839 Cr | +10.1% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SYNGENE vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 VIJAYA VIJAYA | — | — | Pending | 17.9% | — |
 METROPOLIS METROPOLIS | — | — | Pending | 12.6% | — |
 THYROCARE THYROCARE | — | — | Pending | 16.7% | — |
Click a ticker to view its fair-value analysis.
Dividend History
7 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹4.75/sh
Last payout
2025-06-27
₹1.25
Peak payout
₹1.25
Trailing yield
0.27%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Syngene International Limited (SYNGENE.NS) trades at 455.35 vs a model fair value of 249.76, a gap of -45.1%. Piotroski F-score: 7/9. Moa...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of SYNGENE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SYNGENE →
Compare
Head-to-head with peers
Compare SYNGENE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SYNGENENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.